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Abstract
The genetic consult is very important in the diagnosis of early fetal
malformations and its complications at birth and after it. Our research is based on a
3-year research on 6097 pregnant women who underwent screening Bi-Test or
Triple Test. We discovered 408 pregnant women who were found positive and
needed amniocentesis for a diagnostic of certitude. Out of them, 14 had a positive
result from which 10 were found with Down syndrome and 4 with Edwards syn-
drome. In Romania, amniocentesis has become the most used method of prenatal
diagnosis for pregnant women at 35 or above with a family history of hereditary
congenital anomalies. However, the latest screening test from maternal blood, the
Panorama test, can discover many malformations (for chromosomes 21, 18, and 13
and the abnormality of the sex chromosome). The accuracy for false positive is 2%
and false negative 98%. In that light, the purpose of our study is to decrease the use
of amniocentesis and to introduce the latest tests (Panoramic) for the early diagno-
sis of fetal malformation, the use of maternal blood, and the avoidance of using
invasive medical procedures.
Keywords: screening Bi-Test,Triple Test, Panorama Test, amniocentesis for early
detection of fetal malformations
1. Introduction
Talking with the patient about his or her family medical history, such as if the
couple had a person with Down syndrome in their family or any other malforma-
tion, is important. That can be considered as a ‘genetic consultation’ in order to find
out about any possible genetic problems before screening or any other tests. The
specialist tries, in the first place, to make the patient understand the nature of his
disease he is confronting, what’s the most possible evolution of it, and last but not
least what are the possibilities of treating it. A major objective of the genetic consult
is to make the patient understand what are the factors that lead to the development
of the disease, what are the mechanisms that transmit the disease, and how high is
the risk of appearance to other family members. The doctor establishes, after run-
ning different tests, the correct diagnosis of the disease, its evolution, its prognosis,
as well as the possibilities of treatment for a higher quality of life.
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The genetic consult is very important in the diagnosis of early fetal
malformations and their complications at birth and after it. The consult is necessary
for pregnant women with high risk in developing a malformation (e.g., if the
woman has in the family history a newborn with malformations, if she gave birth
before to a baby with malformations, if she lives in a toxic environment).
In Romania, it is mandatory that every pregnant woman should do the BI-TEST
or TRIPLE TEST, depending on the pregnancy weeks.
The cytogenetic prenatal diagnosis refers to early detection of intrauterine fetal
abnormalities and genetic malformations, very often determined by genetics, which
complicate and threaten the life of 3–5% of newborn. These abnormalities explain
the 20% deaths in the newborn period and the much higher percentage of deaths in
childhood and puberty [1]. From the fetal abnormalities, 95% are unexpected and
appear at pregnancies that are not considered at risk for these situations. They can
be light or severe.
The severe abnormalities are not compatible with life or can cause a long-term
handicap [2].
There are multiple purposes for the detection of intrauterine prenatal illness
such as:
• Establishing the high-risk diagnosis and possibly the termination of the
pregnancy (abortion), the pregnancy representing a high risk of death both for
the mother and fetus
• Identifying a situation that can influence the date, the place, or the childbirth
method
• Identifying fetuses that will benefit of early pediatric intervention
• Identifying situations that can affect future pregnancies
Opinions are different when it comes to knowing the diagnosis; many families
decide to keep the pregnancy even if there are severe malformations, thinking that
they can fight this problem by taking care of the baby and not terminating the
pregnancy. But most of the families decide to terminate the pregnancies and seek
treatments for future pregnancies.
In conclusion, the most important thing in the prenatal diagnosis is obtaining
very early in the pregnancy of correct informations about the fetus and making a
correct and easy decision in conformity with family principles [3].
The indications for prenatal diagnosis are:
• Pregnancy—women at age of 35 or above
• Husband aged 45 or above
• Past pregnancy with a fetus with chromosomal abnormality
• One of the parents has a chromosomal abnormality including being a carrier of
a balanced translocation or other structural rearrangements
• Down syndrome
• Pregnancies with risk of Mendelian or polygenic diseases (e.g., Tay-Sachs
disease)
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• Abnormal fetus diagnosed by the ultrasound procedure within the first weeks
of pregnancy
• Maternal anxiety
• Determination of fetal risk in pregnancies with high risk for hereditary x-linked
diseases, for that there is not yet a specific prenatal diagnosis (it is obtained
better by determining the Y-chromosomal material with the new ADN
techniques)
• History of two or more abortions without the possibility of effectuation of the
cytogenic analysis to both parents or a noninvasive prenatal diagnosis [4]
The screening programs focus on the most common chromosomal abnormality—
the Down syndrome (trisomy 21)—and they not only detect very often other fetal
abnormalities.
2. The BI-TEST
The screening of the first trimester is a prenatal text that offers informations
about early pregnancy and the risk of the baby to develop some specific chromo-
somal abnormalities—the Down syndrome (trisomy 21) and the Edwards syndrome
(trisomy 18).
The Down syndrome determines a lifetime affectation of the mental and social
development and also some physical modifications. As for Edwards syndrome, it is
a much more severe condition, and often it is fatal until the early age of 1 year [5].
The screening tests from the first trimester of pregnancy do not evaluate the risk
of defects of the neural tube, such as spina bifida.
We do the BI-TEST (the screening of the first trimester in pregnancy) because it
can be done much earlier than other tests of screening; the results can be available
in the first weeks of pregnancy, which offers the parents much more time in taking
the best decision regarding additional tests, medical treatment, and the course of
pregnancy [6].
Normally, the screening of the first trimester (the BI-TEST) is made between
weeks 11 and 14 of pregnancy. The results of the test are formulated as positive or
negative and also like a probability, e.g., 1:5000 risk to have a baby with Down
syndrome. In general, the test is considered positive if the risk is 1:300 or above. The
BI-TEST implies two steps: a blood test that measures the level of two hormones
that are specific in pregnancy (pregnancy-associated plasma protein A (PAPP-A)
and human chorionic gonadotropin (hCG)) and an ultrasound examination which
measures the size of the transparent space behind the neck of the fetus (the nuchal
translucency) [7]. Correlating the values obtained from the blood tests with the
ultrasound examination and some specific parameters of the mother (age, height,
weight, blood pressure, smoking, diabetes, assisted reproductive techniques), the
specialist can calculate the risk of the mother of having a baby with chromosomal
abnormalities [6].
Frequently, a positive result will enforce the performance of secondary
diagnosis tests:
• The chorial biopsy—it is done normally in the first trimester of pregnancy, and
it is an invasive test which implies cropping a piece of the placenta, with a low
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risk of abortion. It is used to detect chromosomal abnormalities, like the Down
syndrome.
• Amniocentesis—it can be used to identify chromosomal abnormalities but also
defects of the neural tube, like spina bifida. During the amniocentesis, which
frequently is done in the second trimester of pregnancy, a small amount of
amniotic liquid is estranged. It also had a low risk of abortion [6].
3. The TRIPLE TEST
A continuance of the BI-TEST from the first trimester and the screening TRIPLE
TEST (made in the second trimester of pregnancy) is more and more often
requested by us. With the help of it, we can evaluate the risks of the baby develop-
ing a neural tube disorder (spina bifida) or chromosomal abnormalities such as the
Down syndrome (trisomy 21) or the Edwards syndrome (trisomy 18) [6].
Between the 15 and 20 weeks of pregnancy (with optimal results in the weeks
16–18), pregnant women can be tested with a simple blood test known as the
TRIPLE TEST (or triple marker test or second trimester screening). It is made in
combination with an ultrasound examination [3].
For the triple marker testing, a blood test is required that will measure the
levels of:
• hCG (human chorionic gonadotropin) secreted by the placenta.
• Unconjugated estriol, a product of the placenta and the fetus.
• Alpha-fetoprotein (AFP gene) produced by the fetus’s liver.
• Sometimes it also tested the inhibin A (produced by the placenta), because it
considerably grows the chances of detection of the Down syndrome, which is
also known as the quadruple test.
The level of each substance present in the blood helps the doctor identify if
the fetus is exposed to the risk of developing congenital disorders and chromosomal
abnormalities. Exactly as in the case of the BI-TEST, multiples of the median (MoM)
is measured depending on the clinical data of the mother (age, height, weight, race,
smoker, age of the fetus) [4]. The results of the tests are available in 2 weeks from the
blood tests. Usually, if the results of the TRIPLE TEST show a high level of alpha-
fetoprotein, it indicates a neural tube defect. The doctor will recommend an ultra-
sound examination of the fetal cranium and spinal cord. The mother is also purposed
to do an amniocentesis, which involves extracting a small amount of amniotic liquid
from the uterus for further investigation.
On the other hand, low levels of alpha-fetoprotein (AFP) and unconjugated
estriol indicate a high risk of Down syndrome. In this situation, it is recommended
that an amniocentesis should be done.
4. Amniocentesis
Amniocentesis is a medical procedure used in prenatal diagnosis of chromosomal
abnormalities, in which a small amount of amniotic fluid which contains fetal
tissues is sampled from the amniotic sac and which is afterward tested.
It is a two-person procedure which requires a lot of experience and care from the
side of the doctor. One of the doctors assures the ultrasound examination, and the
4
Modern Medical Genetics and Genomics
other doctor places the puncture needle. This way, he can manipulate the needle
with all the attention and care to attain the desired target. There has to be an
incredible collaboration between both doctors, because they have to anticipate each
other’s moves.
Before the procedure, it is mandatory that the sanguine groups ABO and RH be
determined and also to perform an ultrasound examination, which will determine
the number of fetuses, the position and viability, the localization of the placenta, the
amount of amniotic fluid, and the largest amniotic sac that will be punctured and
will assure that the fetus is anatomically normal. Also the gestational age of the fetus
by the fetal biparietal diameter, the length of the thigh bone, and the abdominal
circumference is determined.
Choosing the place of puncture is made after the initial evaluation. When
doing the amniocentesis, it is important to choose the place of the puncture needle
in the amniotic cavity wisely, namely by carefully avoiding the placenta, the
umbilical cord insertion place and the fetus. Colored Doppler ultrasound can
facilitate the choosing of the place for the transplacental puncture, to avoid fetal
hemorrhage.
Diagnosis of chromosomal abnormalities and diagnosis of the neural tube defects
are the most common indications for amniocentesis in the beginning of the second
trimester of pregnancy. As for the evaluation of the fetal pulmonary maturation, it
is the most common indication for amniocentesis in the third trimester [8].
At the end of the first trimester and the beginning of the second trimester, the
indications for amniocentesis are:
• Cytogenetic diagnosis
• Diagnosis of neural tube defects
• Diagnosis of metabolic disorders
At the end of the second trimester and the beginning of the third trimester, the
indications for amniocentesis are:
• Evaluation of the severity of Rh immunization
• Evaluation of fetal pulmonary maturation
• Diagnosis of intra-amniotic infections
• Confirmation of the ruptured membranes
Last, but not the least, the therapeutic purpose of the amniocentesis has indica-
tions in the polyhydramnios drainage and the medical treatment of fetal diseases.
Ultrasound examination (localization of the placenta, fetus, and amniotic liquid
bag) and the insertion of the needle can take up to 20 min. Extraction of the
amniotic liquid can take up to 5 min.
Some women don’t feel pain (painless procedure), while other pregnant women
feel cramps as the needle punctures the uterus or a pressure sensation during the
procedure of extracting amniotic liquid.
Local anesthetic is not normally used. Associated factors to the high level of pain
during the amniocentesis are considered to be maternal anxiety, presence of men-
strual cramps in the past, an anterior amniocentesis, and the insertion of the needle
in the inferior part of the uterus, where the pain is less felt by the patient [9],
although there aren’t any data to support this practice [10].
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5. Panoramic Test
The Panorama Test is a prenatal noninvasive test, which analyzes the fetal DNA
from the maternal blood and establishes the risk of common fetal aneuploidies in
pregnant women, most interestingly the 21, 18, and 13 chromosomes but also the
analyzes the sexual chromosomes X and Y.
Aneuploidies are chromosomal abnormalities characterized by the alteration of
the number of chromosomes, for example, more or less chromosomes instead of the
exact number of chromosomes; the trisomy, when there is an extra chromosome; or
monosomy, when there is missing a chromosome.
Trisomy 21 is caused by the presence of an extra chromosome to the 21st pair,
and it’s known as the Down syndrome. It is the most frequent cause of mental
retardation. The patients with Down syndrome present cardiac disease or other
diseases which require surgical interventions or specific medical treatment. Other
symptoms are, for example, ophthalmological problems [11].
Trisomy 18 is caused by the presence of an extra chromosome to the 18th pair,
and it’s known as the Edwards syndrome. It is a serious cause of mental retardation.
The majority of the children with trisomy 18 present severe cerebral malformations,
severe heart malformations, or severe malformations of other organs. Often, the
growth retardation is found, which can lead to the termination of pregnancy (abor-
tion). Most of the children who are born with the growth retardation die within
their first year of life. Patients who survive present severe intellectual disability and
have problems of growth and development [12].
Trisomy 13 is caused by the presence of an extra chromosome to the 13th pair,
and it’s known as the Patau syndrome. It is a cause of severe mental retardation. The
majority of the patients present serious cerebral and other organs abnormalities. In
many situations the pregnancy doesn’t get to its due date, and the newborn dies
very fast. Half of the born babies die in their first month of life, and 90% from those
who survive in the first year of life present heart malformations, renal
malformations, and renal malformations.
Aneuploidies of the sexual chromosomes are caused by the presence or the
absence of one of the sexual chromosomes. The test can detect the risk for XXX,
XYY, XXYY, and XXY (the Klinefelter Syndrome) and for the X monosomy (the
Turner syndrome). A significant variability exists in regarding the severity of these
genetic conditions, but the majority of the affected individuals are characterized by
slight modifications physically and mentally.
During pregnancy some fragments of the fetal DNA run through the maternal
blood. The fetal DNA is detectable since the 5th week of pregnancy. The concen-
tration increases successively in the next weeks of pregnancy and disappears right
after childbirth. The circulating fetal DNA quantity is found from the 9th to 10th
weeks of pregnancy, and it’s sufficient to guarantee the relevance and the sensibility
of the Panorama Test.
The test is done by collecting a blood sample from the pregnant woman from at
least the 10th week of unique and twin pregnancies. In the laboratory a complex
analysis is made, where the fetal DNA from the maternal blood is isolated. This
procedure identifies the eventual chromosomal abnormalities, like aneuploidy, and
cutting-edge sequencing technology is used, along with advanced bioinformatics
analysis.
The results obtained in the Panorama Test are:
• “High risk” implies that there is a probability that the fetus can present an
aneuploidy of the 21st, 18th, and 13th pairs of chromosomes or an aneuploidy of
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X and Y sexual chromosomes. This result indicates that there is a high chance
that the fetus can present one of the abovementioned abnormalities, but it is
not sure the fetus will have that condition. The endorsed advice is an invasive
prenatal diagnosis test, like chorionic villus biopsy or amniocentesis.
• “Low risk” implies that the test detected a risk <1/10,000 (0.01%) for the fetus
to be affected by a chromosomal aneuploidy.
• In some cases, when the quantity of fetal DNA is not enough, the test can show.
• Incomplete results or no results. In this situation, a new blood sample will be
collected for the repetition of the test. In case the sexual analysis is demanded,
this result can also be provided.
The accuracy of the Panorama Test
The test can detect the risk of a sexual chromosomal aneuploidy with a rate of
detection which varies depending on the type of detected aneuploidy: 13th, 18th,
and 21st.
The test was validated for women with unique and twin pregnancies, with at
least 10 weeks of pregnancy. This test evaluates just the chromosomal aneuploidies
of the 13th, 18th, 21st, X, and Y. In the case of pregnancy with more fetuses,
informations about the sexual chromosomes will not be provided. This procedure
does not replace the invasive prenatal diagnosis (choriocentesis or amniocentesis).
Also, the analysis cannot highlight the equilibrated chromosomal
rearrangements, partial abnormalities of the analyzed chromosomes, structural
chromosome abnormalities, fetal or placental chromosomal mosaicism in a small
percentage (the presence of two cellular lines with a different set of chromosomes,
with a cellular line weakly represented), point mutations, methylation defects, and
polyploidy. In particular, the analysis does not reveal the presence of hereditary
genetic disorders with the Mendelian transmission. The test can give a false-positive
result in the case of chromosomal mosaicism, but this thing can limit itself to the
placenta. The sex of the fetus is mentioned as masculine or feminine, based on the
presence or absence of the Y chromosome, not on the presence or absence of the
SRY gene.
Pregnancies with abnormal ultrasound results should be studied with other
types of prenatal investigations, such as fetal karyotype from the chorionic villi or
amniotic liquid. Although this test is very precise, the results are not a diagnosis,
and they should be evaluated in the clinical context of the patient and the family
medical history. The test is limited to offer just informations about the risks of
aneuploidies for the analyzed chromosomes.
A “low-risk” result can significantly reduce the possibility for the fetus to
present an aneuploidy of the examined chromosomes, but it cannot guarantee that
these chromosomes are normal or that the fetus is healthy.
% diagnosis (sensibility) % false positive ( specificity)
Trisomy 21 (the Down syndrome) 99 (>99%) <0.1% (>99%)
Trisomy 18 (the Edwards syndrome) 99 (>99%) <0.1% (>99%)
Trisomy 13 (the Patau syndrome) 08/10/16 <0.1% (>99%)
Determination of the fetal sex 99 (>99%) <0.1% (>99%)
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This test can be done for 13th, 18th, and 21st aneuploidies also in case of twin
pregnancies and of pregnancies obtained by fertilization in vitro.
This study seeks the degree of accuracy of the prenatal screening which
indicates a high risk. The results are established after the confirmation or informa-
tion of the diagnosis by the invasive diagnosis method for genetical abnormalities,
the amniocentesis procedure. The interventions have been made by the
obstetrician, helped by different doctors, based on the “2 operatives” technique.
The puncture and the extraction of the amniotic liquid will be done by the
obstetrician, and the doctor helping him would monitor by ultrasound the whole
intervention.
Our study is based on a 3-year research (2012–2015). We evaluated 6097
pregnant women, from which 408 had an indication for effectuation of amniocen-
tesis with the purpose of establishing a correct diagnosis. The dynamics of the
number of pregnancies in the analyzed period presents significant decreases from
15%–14.65% in 2014 to 11.15% in 2015.
From the total amount of 408, 114 were made in the year 2012, 102 in the year
2013, 97 in the year 2014, and 95 in the year 2015.
Comparing the dynamics of the number of amniocentesis procedures done in
2015 with the amniocentesis procedures done in 2012, they have a pronounced
decreasing rhythm, so that in 2013 the level decreased by 10.53%, in 2014 the level
decreased by 14.91%, and in 2015 the level decreased by 16.67% due do the appari-
tion of the Panorama Test sampled from the maternal blood.
By the fact that, in medical practice, age above 35 years old in pregnant women
represents a risk factor; the patients have been divided in two groups such as
patients aged until 35 years old and patients above 35 years old.
Year Number of pregnancies Number of amniocentesis
2012 1641 114
2013 1596 102
2014 1402 97
2015 1458 95
TOTAL 6097 408
Year Number of
pregnancies
Number of amniocentesis
procedures
Dynamics than 2012
Number of
pregnancies
Number of amniocentesis
procedures
2012 1641 114 – –
2013 1596 102 97.26 89.47
2014 1402 97 85.44 85.09
2015 1458 95 88.85 83.33
Total 6097 408 – –
Group of age 2012 2013 2014 2015 TOTAL
Under 35 years old 74 66 57 54 251
Above 35 years old 40 36 40 41 157
Total number of patients 114 102 97 95 408
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In the year of our study, 408 amniocentesis procedures have been made. Two
hundred and fifty-one procedures were done on patients with age under 35 years old,
which represents a percentage of 61.5%. One hundred and fifty-seven procedures
were made on patients with age above 35 years old, with a percentage of 38.5%.
The distribution of the patients based on the pregnancy period and the number
of amniocentesis procedures done in percentage:
Even though the number of amniocentesis procedures has slightly decreased, the
number of BI-TESTS has significantly increased since year 2012. In year 2013, the
increasing number has been a percentage of +115.4%, in 2013 it has been +315.45%,
and in the year 2015, it has been 269.2%. In the last 2 years, the percentage for
positive tests for Down syndrome in amniocentesis has been 50%. In all our period
of research, 35.05% of the patients have effectuated the double-positive test for the
Down syndrome.
In the period of our research, the percentage for Down syndrome and Edwards
syndrome of the TRIPLE TEST decreased in relation to the number of amniocente-
sis procedures. In this period the result positive for these tests is considered:
• In 2012 the test for Down syndrome represented 81.58%, and 4.39% for
Edwards syndrome.
• In 2013 the test for Down syndrome represented 62.75% and 2.94% for Edwards
syndrome.
Year Number of
amniocentesis
procedures
Triple Test positive
for Down syndrome
Triple Test positive
for Edwards
syndrome
Percentage of positive
Triple Test (minus
the number of
amniocentesis
procedures) for:
Down
syndrome
Edwards
syndrome
2012 114 93 5 81 4.39
2013 102 64 3 62.75 2.94
2014 97 36 1 37.11 1.03
2015 95 33 1 34.74 1.05
Total 408 226 10 55.39 2.45
Weeks of pregnancy 2012 2013 2014 2015 Total %
Week 15 15 15 14 14 58 14.22
Week 16 36 34 32 39 141 34.56
Week 17 31 28 26 24 109 26.72
Week 18 14 13 IO 8 45 11.03
Week 19 9 5 10 6 30 7.35
Week 20 7 5 3 2 17 4.17
Week 21 2 2 2 2 8 1.96
Total 114 102 97 95 408 100%
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• In 2014 the test for Down syndrome represented 37.11% and 1.03% for the
Edwards syndrome.
Although in 2012 the highest number of amniocentesis procedures (114) was
recorded, a single case was recorded in which amniocentesis had as an indication
the maternal age, which represents a percentage of 0.88%. In 2013, a slight increase
with a percentage of 6.86% is noted (in 2014, 4.12%, and in 2015, 3.16%). In all,
there were 15 procedures made after the indication of the maternal age above 35
years old, with a percentage of 3.68%.
The distribution of the amniocentesis procedures based on priors:
• Down syndrome in the family
• Prior pregnancy with Down syndrome
• Prior pregnancy with Turner syndrome
It is observed that in 2012, from the amount of 114 amniocentesis procedures, 2
of them had as indication the pathological chromosomal history. One of the patients
presents in her family history a member of the family who has Down syndrome.
Another patient had a prior pregnancy with Down syndrome. These indications
represent 1.75% of the indications for year 2012. In 2014 two more pregnant women
have been diagnosed. One of them was coming from a family with Down syndrome,
and the other one had a prior pregnancy with Turner syndrome. These indications
represent a percentage of 2.61% for the year 2014.
From a total of 408 pregnancies, the indications for pathological chromosomal
history represent a percentage of 0.97%.
Year Number of
amniocentesis
procedures
Down syndrome
in the family
Prior pregnancy with
Down syndrome
Prior pregnancy with
Turner syndrome
2012 114 1 1 0
2013 102 0 0 0
2014 97 1 0 1
2015 95 0 0 0
Year Number of amniocentesis procedures Age of the mother >35 Percentage %
2012 114 1 0.88
2013 102 7 6.86
2014 97 4 4.12
2015 95 3 3.16
Total 408 15 3.68
Number of amniocentesis procedures 408 100%
BI-TEST 131 32.10%
TRIPLE TEST 258 63.23%
Indication for maternal age 35 years or above 15 3.67%
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From the amount of 408 pregnancies which underwent the amniocentesis pro-
cedure, 149 of them were on their first pregnancy, with a percentage of 36.52%. One
hundred and ninety-eight of the pregnant women were on their second pregnancy
(48.53%), and 61 were on their third or more pregnancy (14.95%).
Distribution of the patients depending on environmental residence
It is concluded that only 23.28% of the pregnant women came from a rural
environment; the rest of 76.72% came from an urban environment.
Distribution of patients depending on chronic diseases
Distribution of patients depending on vicious behavior
It can be observed that, despite the fact that smoking affects the pregnancy and
the fetus, a quite high percentage of pregnant women smoke (39.22%).
Distribution of the patients depending on the result of the amniocentesis
The percentage of Down syndrome reported to the total number of pregnancies
(6097 patients) represents 1.6% above the European statistics. The percentage of
Edwards syndrome reported to the total number of pregnancies represents 0.656%
above the European statistics.
Environment 2012 2013 2014 2015 Total %
Rural 16 34 25 20 95 23.28
Urban 98 68 72 75 313 76.72
Total 114 102 97 95 408 100
Chronic diseases Number of patients %
Diabetes mellitus 11 2.70
Hepatitis A and hepatitis B 5 1.23
High blood pressure 9 2.21
Obesity 10 2.45
Kidney diseases 3 0.74
2012 2013 2014 2015 Total %
Smoker 38 49 36 37 160 39.22
Non-smoker 76 53 61 58 248 60.78
Total 114 102 97 95 408 100
Down syndrome in the family history 2 0.49%
Prior pregnancy with Down syndrome 1 0.24%
Prior pregnancy with Turner syndrome 1 0.24%
Result Number of patients %
Normal results 394 96.57
Down syndrome 10 2.45
Edwards syndrome 4 0.98
Total 408 100
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Maternal ages for women diagnosed with pregnancies with Down syndrome
were 28, 31, 32, 38, and 40 years old.
All the patients with babies diagnosed with Down syndrome or Edwards syn-
drome decided to terminate the pregnancy.
The 14 cases positive for Down syndrome and Edwards syndrome (4 cases
positive for Edwards syndrome and 10 cases positive for Down syndrome) were
actually found because of the indications of the TRIPLE TEST, 4 more cases positive
for Down syndrome were found because of the indications for BI-TEST, and just 1
case of Down syndrome was found because of the indications for maternal age.
Amniocentesis has become the most used prenatal diagnosis method for women
aged 35 and above or even for younger women with a family history specific for
hereditary congenital abnormalities.
In our studied group, 157 pregnant women asked for a prenatal diagnosis for
Down syndrome. They were aged 35 or above 35 and demanded the association of
some pathological biochemical markers (double test, TRIPLE TEST).
The frequency of the structural chromosomal abnormalities (translocations,
deletions, inversions) did not show a similar numeric relationship regarding the
maternal age.
According to the literature, the screening tests have a margin of error in the
diagnosis of fetal malformations, so the diagnosis of certainty will result after the
amniocentesis.
The majority of the specialists consider that amniocentesis is an invasive
procedure, so it is recommended that the number of these procedures should be
decreased. In this regard, our study did very well: the result of the utilization of
the other methods (BI-TEST, TRIPLE TEST) was positive. The BI-TEST
can detect trisomy 21 (the Down syndrome) and trisomy 18 (the Edwards syndrome).
There are tests like Panorama Test which are cutting-edge technology, and they
reduce the use of amniocentesis. But the cost of this test is high and not covered by
the National Health, which is the reason why it is not accessible for all patients.
Our study has been made on a large segment of the population which had access
to all the screening tests (BI-TEST, TRIPLE TEST), but not all of the patients had
this possibility.
The TRIPLE TEST in pregnancy can help in tracking down the neural tube
defects and chromosomal abnormalities such as trisomy 18 and trisomy 21. So, if a
high level of alpha-fetoprotein (AFP gene) is found in the blood, it is likely that the
fetus presents a neural tube defect (more exactly the brain and the spinal cord),
defects such as spina bifida or anencephaly. If the results of the TRIPLE TEST show
a low level of alpha-fetoprotein (AFP gene) and estriol, it can indicate trisomy 21
(the Down syndrome), trisomy 18 (Edwards syndrome), or other chromosomal
abnormalities.
Before we proceeded with the amniocentesis procedure, we acquired from every
patient and her partner a written consent after informing them about what the
procedure implies.
Age of the mother diagnosed with pregnancies with Down syndrome Number of cases
28 2
31 1
32 2
38 3
40 2
12
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In obstetrical practice the risk of carrying out an amniocentesis is evaluated
permanently, compared to the individual risk of numerical chromosomal abnor-
malities or structural chromosomal abnormalities. We recommend the amniocente-
sis as an invasive diagnosis prenatal method when the risk of a detectable
abnormality is higher than the risk of the procedure itself.
It is important that the patient should be informed about the pam felt during the
amniocentesis.
Numerical chromosomal abnormalities (aneuploidies)—in the case of amnio-
centesis procedures done to pregnant women with age 35 or above from our con-
signment—have a frequency of 3.18% (5 cases out of 157).
The majority of the patients questioned said that the procedure was a painful
method. Pain is a multidimensional sensation and complex, which varies in quality,
intensity, duration, localization, and inconvenience from an individual to another.
The intensity and inconvenience of the pain is not directly connected to the nature
and the extension of the tissue lesion. Cultural, genetic, familial, growth, psycho-
logical, and social variables have a strong impact in the perception of the pain and in
its expression from the patient.
The objective quantification of the pain is difficult. Before any invasive proce-
dure effectuated throughout pregnancy, the biggest concern of the patient is the
risk and the intensity of the pain during procedures.
Ultrasound conclusions in cases of chromosomal abnormalities
6. Conclusions
In conclusion, all the pregnant women who underwent the amniocentesis pro-
cedure and had a negative result had an on-term pregnancy and delivered healthy
newborn babies.
As for the pregnant women who underwent the amniocentesis procedure and
had a positive result, all of them decided to terminate their pregnancy due to
existent fetal malformations.
Trisomy Ultrasound conclusions
Trisomy 21 (Down
syndrome)
• Duodenal atresia, tracheoesophageal fistula, and hydramnios are present
usually if there are gastrointestinal damages
• Heart abnormalities—defects of the atrial septum
• Hypoplasia of the middle phalanx of the 5th finger of the hand
• Conclusions from the second trimester: increased cervical skinfold
(>6 mm), ratio of the actual femur (length), and the expected
femur = 0.91
Trisomy 18 (Edwards
syndrome)
• Growth retardation in uterus
• Hydramnios
• Hand wrapped with superimposed fingers (the index covers the third
finger, and the fifth finger covers the fourth finger)
• Ankle equinus with prominent calcaneus and clubfoot.
• Heart abnormalities: ventricular septal defect
• Omphalocele, diaphragmatic hernia
• Cyst of the choroid plexus
Trisomy 13 (Patau
syndrome )
• Holoprosencephaly (defects of the facial break line)
• Cleft palate
• Heart abnormalities such as ventricular septal defect
• Polydactylism
• Omphalocele
• Polycystic kidneys
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The purpose of our study was to decrease the use of amniocentesis procedures
and to introduce a cutting-edge technology, which is the Panorama Test for early
diagnosis of fetal malformations. We tried to implement a noninvasive method
(Panorama Test made from the mother’s blood sample) over an invasive method
which is the amniocentesis.
Our purpose has been achieved by the decrease of amniocentesis and by
increasing the use of cutting-edge technology without affecting the final results in
the percentage of the fetal malformations statistics worldwide.
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